Skip to content

Effect of Brain-gut Coherence method of acupuncture on Gastrointestinal Function Following Colorectal Cancer Surgery

Effect of Brain-gut Coherence method of acupuncture on Gastrointestinal Function Following Colorectal Cancer Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000563
Enrollment
Unknown
Registered
2025-03-20
Start date
2023-02-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Function Following Colorectal Cancer Surgery

Interventions

control group:conventional Western medical treatment and acupuncture methods
observation group:conventional Western medical treatment and acupuncture using the Brain-gut Coherence method

Sponsors

The Second Affiliated Hospital of Hunan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Undergo laparoscopic or open surgery for colorectal cancer and meet the diagnostic criteria for postoperative gastrointestinal dysfunction in colorectal cancer; 2. Be between the ages of 18 and 65 years old in a stable condition with clear consciousness and stable vital signs; 3. Have good communication skills and can fully understand and cooperate in completing the assessment of relevant scales; 4. Willing to accept acupuncture treatment sign the informed consent form and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with a preoperative definitive diagnosis of gastrointestinal dysfunction due to other non-surgical factors or diseases such as gastroduodenal ulcers chronic constipation irritable bowel syndrome ulcerative colitis; 2. Serious postoperative complications such as gastrointestinal or abdominal bleeding gastrointestinal fistula abdominal infection mechanical intestinal obstruction; 3. Serious cardiovascular cerebrovascular hepatic renal and hematopoietic system diseases or diabetes mellitus malignant tumors mental illness connective tissue disease hemophilia and bleeding tendency; 4. Unconsciousness intellectual disability unable to cooperate with the treatment; (5) contraindications to needling. If the patient has any of the above it should be excluded.

Design outcomes

Primary

MeasureTime frame
the time to first postoperative flatus;the time to first postoperative defecation;

Secondary

MeasureTime frame
Serum gastrin;Overall efficacy;Serum motilin;the postoperative abdominal bloating score;The number of postoperative episodes of nausea or vomiting per day;Serum ghrelin;the gastrointestinal symptoms score;length of postoperative hospitalization;the postoperative recovery quality score;

Countries

China

Contacts

Public ContactKe He

The Second Affiliated Hospital of Hunan University of Chinese Medicine

178077878@qq.com13786155347

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026